Latest / Stinchfield with Grant Stinchfield
The GLP-1 Gold Rush: What Millions of Americans Aren't Being Told
America is in the middle of a GLP-1 gold rush. Millions are turning to drugs like Ozempic, Wegovy and tirzepatide for dramatic weight loss. But are doctors and weight-loss clinics doing it wrong?
These drugs can deliver impressive results, but there are important questions about dosing, muscle loss, side effects, nutrition and what happens when the weight comes off. Most importantly, is there a smarter way to use GLP-1s while protecting your long-term health?
My guest is Peter Gillooly, CEO of The Wellness Company, which itself offers tirzepatide. So this isn't an anti-GLP-1 conversation…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.